Treatment of glutathione synthetase deficient fibroblasts by inhibiting gamma-glutamyl transpeptidase activity with serine and borate.
D001881:Borates / Q000494:pharmacology*; D002478:Cells, Cultured; D005347:Fibroblasts / Q000201:enzymology; D005978:Glutathione / Q000378:metabolism; D005981:Glutathione Synthase / Q000172:deficiency*; D006801:Humans; D007700:Kinetics; D010453:Peptide Synthases / Q000172:deficiency*; D012694:Serine / Q000494:pharmacology*; D012867:Skin / Q000201:enzymology*; D005723:gamma-Glutamyltransferase / Q000037:antagonists & inhibitors*
D001881:Borates; D012694:Serine; D005723:gamma-Glutamyltransferase; D010453:Peptide Synthases; D005981:Glutathione Synthase; D005978:Glutathione